Eveline Daetwyler Alfred Zippelius Peter Meyer Heinz Läubli
10.3389/fimmu.2023.1171981
Front Immunol
2023 May 9;14:1171981.
pd-1/l1 case report immune checkpoint inhibitor (ici) immune-related adverse event(s) neuropathic optic neuropathy
CC BY
https://pubmed.ncbi.nlm.nih.gov/37228591/
Hodgkin Disease / drug therapy Optic Nerve Diseases / chemically induced Optic Nerve Diseases / diagnosis Optic Nerve Diseases / therapy
Hodgkin Disease / drug therapy Optic Nerve Diseases / chemically induced Optic Nerve Diseases / diagnosis Optic Nerve Diseases / therapy Case Reports Antibodies, Monoclonal, Humanized / adverse effects Humans Mycophenolic Acid pembrolizumab Mycophenolic Acid Antibodies, Monoclonal, Humanized
PMC10203429
37228591
Pembrolizumab-induced optic neuropathy - a case report
2023